Rynex DM Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride 2.5 mg/5mL; 1 mg/5mL; 5 mg/5mL Liquid, 473 mL — NDC 00485-0204-16 package photo

Rynex DM Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride 2.5 mg/5mL; 1 mg/5mL; 5 mg/5mL Liquid, 473 mL

by Edwards Pharmaceuticals, Inc · 473 mL in 1 BOTTLE (0485-0204-16)
NDC 00485-0204-16
🏷️ FDA NDC (as labeled) 0485-0204-16 billing pads the labeler segment with a zero
This package
Contains473 mL Cost per mL$0.0514 NADAC Per package$24.31 / 473 ml Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.0824/unit — full pricing hub ↓
Also comes in: 118 ml 00485-0204-04
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 0485-0204-16
Product NDC 0485-0204
11-digit billing NDC 00485020416
NCPDP billing unit ML — per mL (volume)
RxCUI 1090463
UNII 04JA59TNSJ, IXA7C9ZN03, 9D2RTI9KYH
Application # M012
SPL Set ID 7be2c282-24ba-4f19-9b14-872d3f5746a7
Established class (EPC) Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist; alpha-1 Adrenergic Agonist
Mechanism of action Adrenergic alpha1-Agonists; Sigma-1 Receptor Agonists; Uncompetitive NMDA Receptor Antagonists
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2011-03-14
Route ORAL
Dosage form LIQUID
Substance PHENYLEPHRINE HYDROCHLORIDE; BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE
GPI-14 43995803080910
GPI class Rynex DM
GCN Seq No 060622
GCN 26808
HICL code 035368
Ingredient (HICL) Brompheniram/Phenylephrine/Dm
HIC1 code B
Therapeutic class — broad (HIC1) Respiratory System
HIC2 code B3
Therapeutic class — intermediate (HIC2) Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code B3R
Therapeutic class — specific (HIC3) Non-Opioid Antitus-1St Gen.antihistamine-Decongest
AHFS code 04:04.20.00
AHFS class Propylamine Derivatives
FDB label name RYNEX DM LIQUID
FDB brand name Rynex Dm
Legend status O — Over-the-counter (OTC) drug or device
Why two NDCs? The FDA registers this code as 0485-0204-16 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00485-0204-16. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Substituted alkylamines class.

Drug family (ATC) Substituted alkylamines
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerEdwards Pharmaceuticals, Inc
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code00485
First marketedMar 2011
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name RYNEX DM LIQUID Ingredient Brompheniram/Phenylephrine/Dm
🧪 What is this product?

Rynex DM is an oral liquid cold and cough product sold over the counter under FDA's OTC monograph rules. It contains three active ingredients commonly used to relieve symptoms associated with the common cold and upper respiratory conditions. Brompheniramine maleate functions as an antihistamine typically used to reduce sneezing and runny nose. Dextromethorphan hydrobromide is a cough suppressant, and phenylephrine hydrochloride is a nasal decongestant, both commonly included in products meant to ease respiratory discomfort.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

FlavorTutti Frutti
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 2968PHW8QP
    A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
  • UNII PDC6A3C0OX
    Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
  • UNII 6DC9Q167V3
    Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
  • UNII SB8ZUX40TY
    Saccharin sodium is an artificial sweetener made from saccharin salt. It's added to medicines to improve taste, especially in liquid formulations for children or bitter drugs.
  • UNII 1Q73Q2JULR
    Sodium citrate is a salt derived from citric acid. It works as a buffer to maintain the medicine's pH level and may also help improve taste or act as a preservative in the formulation.
  • UNII 506T60A25R
    Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

7 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesCitric Acid, Glycerin, Propylene Glycol, Purified Water, Sodium Citrate, Sodium Saccharin, Sorbitol, Tutti Frutti Flavor.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.051 $24.31 / 473 ml
Medicaid paysCMS SDUD · 12 mo $0.0824 $38.98 / 473 ml
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Dec 2021 Aug 2022 Feb 2026 Aug 2026 $0.052 $0.037
▲ Up 37% over the last 19 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Cold and Cough Relief children 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 70677-0121-01 Strategic 1 bottle $0.017 Discontinued save 67%
Rynex DM 2.5 mg/5mL; 1 mg/5mL; 5 mg/5mLthis 00485-0204-16 Edwards 473 ml $0.051 Availability likely
EndaCof DM 1 mg/5mL; 5 mg/5mL; 2.5 mg/5mL 68047-0143-16 Larken 473 ml $0.051 Availability likely
Good Sense Childrens Cold and Cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 00113-0987-26 L. 1 bottle $0.075 Availability likely +46%
dimaphen dm 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 00904-6463-20 Major 1 bottle $0.075 Availability likely +46%
good neighbor pharmacy cold and cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 24385-0519-26 Amerisource 1 bottle $0.075 Availability likely +46%
Signature Care Childrens Cold and Cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 21130-0082-26 Safeway 1 bottle Discontinued
Childrens Cold and Cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 30142-0987-26 Kroger 1 bottle FDA listed
cold and cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 37808-0987-26 H 1 bottle FDA listed
equaline childrens cold and cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 41163-0987-26 United 1 bottle FDA listed
CareOne Childrens Cold and Cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 41520-0987-26 American 1 bottle Discontinued
equate childrens cold and cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 49035-0082-34 Wal-Mart 1 bottle FDA listed
Childrens Cold and Cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 51316-0578-03 CVS 1 bottle FDA listed
Childrens Dimetapp Cold And Cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 51316-0645-08 CVS 1 bottle FDA listed
Pediacare Childrens Cough and Cold Grape 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 52412-0920-01 RANDOB 1 bottle FDA listed
Childrens Metapp Daytime 1 mg/5mL; 5 mg/5mL; 2.5 mg/5mL 53041-0577-03 Guardian 1 bottle FDA listed
Cold and Cough DM 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 56062-0987-26 Publix 1 bottle FDA listed
dimaphen dm 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 68788-8134-01 Preferred 1 bottle FDA listed
Good Sense Childrens Cold and Cough 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 68788-8331-01 Preferred 1 bottle FDA listed
Dimetapp Cold and Cough 1 mg/5mL; 5 mg/5mL; 2.5 mg/5mL 80070-0310-04 Foundation 1 bottle FDA listed
TARGET CHILDRENs COLD and COUGH 2 mg/10mL; 10 mg/10mL; 5 mg/10mL 82442-0645-04 TARGET 1 bottle FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2011
On the market since
Mar 2011
📍
2026
Currently FDA-listed
15 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00485-0204-16, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
40.6K
Units reimbursed last 4 qtrs
8.2M
Gross reimbursed last 4 qtrs
$675.2K
Avg / prescription
$16.64
Avg / unit
$0.0824
Latest quarter Q4 2025
11.1KRx
Medicaid pays / mL
$0.0824
gross reimbursed
vs
NADAC / mL
$0.0514
acquisition cost
=
Spread
+$0.0310
+60% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
14% FFS 86% MCO
Fee-for-service · 5,682 Rx Managed care · 34,896 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 339,285 units · 1,734 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: 247,501 units · 2,664 per 100k residents NJ Massachusetts: no data reported MA California: 409,818 units · 1,052 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 25,794 units · 570 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: 7,327 units · 347 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: 6,925,645 units · 235,566 per 100k residents MS Alabama: no data reported AL Georgia: 154,257 units · 1,399 per 100k residents GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 85,161 units · 279 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
279235,566
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Mississippi 235,566 /100k
2 New Jersey 2,664 /100k
3 New York 1,734 /100k
4 Georgia 1,399 /100k
5 California 1,052 /100k
6 Kentucky 570 /100k
7 New Mexico 347 /100k
8 Texas 279 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
473 ml this page00485-0204-16 40,578 Rx · $675,192
118 ml00485-0204-04 8,289 Rx · $117,164
Drug total (last 4 qtrs): 48,867 Rx · 9,671,079 units · $792,357 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
00485-0204-04 118 mL in 1 BOTTLE, PLASTIC (0485-0204-04) $0.0750 / mL $8.85 2011-03-14 Active
00485-0204-16 You're viewing this 473 mL in 1 BOTTLE (0485-0204-16) $0.0514 / mL $24.32 2011-03-14 Active

You're viewing the largest of 2 pack sizes for this product.

This pack has the lowest per-mL cost of the 2 priced pack sizes ($0.0514 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 83% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in NDC 00485-0204-16?
NDC 00485-0204-16 contains 473 mL — 473 ml in 1 bottle.
What is the difference between NDC 00485-0204-16 and NDC 00485-0204-04?
Both are Rynex DM Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride 2.5 mg/5mL; 1 mg/5mL; 5 mg/5mL Liquid — the drug itself is identical. NDC 00485-0204-16 is the 473 mL package, while NDC 00485-0204-04 is the 118 ml package. Per-mL NADAC also differs: $0.0514 here vs $0.0750 for the 118 ml pack.
What NDC number is used to bill for this package of Rynex DM Brompheniramine Maleate, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride 2.5 mg/5mL; 1 mg/5mL; 5 mg/5mL Liquid?
Bill NDC 00485-0204-16 — the 11-digit billing format is 00485020416. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 45 words

Uses temporarily relieves these symptoms due to the common cold, hay fever, (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of nose or throat itchy, watery eyes cough due to minor throat and bronchial irritation nasal congestion reduces swelling of nasal passages

⏱️ Dosage and Administration 62 words

Directions Do not exceed recommended dosage. Adults and children 12 years of age and older: 4 teaspoonfuls (20 mL) every 4 hours, not to exceed 24 teaspoonfuls in 24 hours. Children 6 to under 12 years of age: 2 teaspoonfuls (10 mL) every 4 hours, not to exceed 12 teaspoonfuls in 24 hours. Children under 6 years of age: Consult a doctor

⚠️ Warnings ~1 min read

Warnings Do not exceed recommended dosage. Do not use this product if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma trouble urinating to to an enlarged prostate gland a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema a cough that occurs with too much phlegm (mucus) heart disease high blood pressure thyroid disease diabetes Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product excitability may occur, especially in children may cause marked drowsiness avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase the drowsiness effect be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache.

A persistent cough may be a sign of a serious condition. new symptoms occur If pregnant or breast-feeding, ask a health professional before use. Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 10 words

Other information Store at 59° - 86°F (15° - 30°C)

🧪 Active Ingredient 20 words

Drug Facts Active ingredients (in each 5 mL teaspoonful) Brompheniramine Maleate 1mg Dextromethorphan Hydrobromide 5 mg Phenylephrine Hydrochloride 2.5 mg

🧪 Inactive Ingredients 17 words

Inactive ingredients Citric Acid, Glycerin, Propylene Glycol, Purified Water, Sodium Citrate, Sodium Saccharin, Sorbitol, Tutti Frutti Flavor.

🎯 Purpose 5 words

Purpose Antihistamine Antitussive Nasal Decongestant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.